Publications in collaboration with researchers from Hospital General Universitario de Valencia (16)

2023

  1. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

  2. Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study

    Oral Diseases, Vol. 29, Núm. 5, pp. 2117-2129

2022

  1. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study

    Future oncology (London, England), Vol. 18, Núm. 35, pp. 3913-3927

2021

  1. Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

    JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169

  2. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

    Gynecologic Oncology, Vol. 161, Núm. 3, pp. 681-686

2020

  1. Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

    Cells, Vol. 9, Núm. 2

2019

  1. Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)

    Clinical and Translational Oncology, Vol. 21, Núm. 3, pp. 380-390

  2. Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Assessment and treatment of breakthrough cancer pain in Spain: A self-audit study

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii611-viii612

  2. Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii612

  3. Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study

    Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 613-618

  4. The quality oncology practice initiative program: Experience in Spain

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii570-viii571

2016

  1. SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)

    Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1237-1242

  2. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan

    Supportive Care in Cancer, Vol. 24, Núm. 1, pp. 499-507

2014

  1. Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists

    Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 914-920

2005

  1. Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: An Oncopaz Cooperative Group Study

    Journal of Clinical Oncology, Vol. 23, Núm. 13, pp. 3104-3111